Recent advances in renal urate transport: Characterization of candidate transporters indicated by genome-wide association studies

Clinical and Experimental Nephrology

Volumn 16, Issue 1, 2012, Pages 89-95

  Anzai, Naohiko ^a,b   Jutabha, Promsuk ^a,b   Amonpatumrat Takahashi, Sirirat ^b   Sakurai, Hiroyuki ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Genome wide association study; Gout; Hyperuricemia; Hypouricemia; Transporter; Urate

Indexed keywords

ALLANTOIN; ANTIPORTER; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEIN; GLUCOSE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER 9; PDZK PROTEIN; SODIUM PHOSPHATE COTRANSPORTER 1; SODIUM PHOSPHATE COTRANSPORTER HOMOLOG; UNCLASSIFIED DRUG; URATE; URATE ANION EXCHANGER; URATE OXIDASE; URATE TRANSPORT RELATED PROTEIN; URATE TRANSPORTOME; URATV1 PROTEIN; URIC ACID; VOLTAGE DEPENDENT URATE TRANSPORTER GLUT9;

APICAL MEMBRANE; BASOLATERAL MEMBRANE; CARDIOVASCULAR DISEASE; GENE LOCUS; GENE SILENCING; GENETIC ASSOCIATION; GOUT; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; MAMMAL; NONHUMAN; PROTEIN ANALYSIS; PURINE METABOLISM; RENAL URATE TRANSPORT; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSPORT AT THE CELLULAR LEVEL; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; GENOME-WIDE ASSOCIATION STUDY; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; HYPERURICEMIA; KIDNEY TUBULES, PROXIMAL; MEMBRANE PROTEINS; MONOCARBOXYLIC ACID TRANSPORTERS; NEOPLASM PROTEINS; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE I; URIC ACID;

EID: 84858276787     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-011-0532-z     Document Type: Review

References (59)

1. Sica DA, Schoolwerth AC. Renal handling of organic anions and cations: excretion of uric acid. In: Brenner BM, editor. The Kidney. 6th ed. Philadelphia: WB Saunders; 2000. p. 680-700.
2. Anzai N, Kanai Y, Endou H. New insights into renal transport of urate. Curr Opin Rheumatol. 2007;19:151-7. (Pubitemid 46208773)
3. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha SH, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002;417: 447-52. (Pubitemid 34563537)
4. Anzai N, Kanai Y, Endou H. Organic anion transporter family: current knowledge. J Pharmacol Sci. 2006;100:411-26. (Pubitemid 44609532)
5. Jutabha P, Kanai Y, Hosoyamada H, Chairoungdua A, Kim DK, Iribe Y, et al. Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule. J Biol Chem. 2003;278:27930-8. (Pubitemid 36899987)
6. van Aubel RA, Smeets PH, van den Heuvel JJ, Russel FG. Human organic anion transporterMRP4 (ABCC4) is an efflux pump for the purine endmetabolite urate withmultiple allosteric substrate binding sites. Am J Physiol Renal Physiol. 2005;288:F327-33. (Pubitemid 40109516)
7. +-coupled transport of lactate. J Biol Chem. 2004;279:44522-32.
8. Gopal E, Umapathy NS, Martin PM, Ananth S, Gnana-Prakasam JP, Becker H, et al. Cloning and functional characterization of human SMCT2 (SLC5A12) and expression pattern of the transporter in kidney. Biochim Biophys Acta. 2007;1768:2690-7.
9. Bahn A, Hagos Y, Reuter S, Balen D, Brzica H, Krick W, et al. Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem. 2008;283:16332-41.
10. Vitart V, Rudan I, Hayward C, Gray NK, Floyd J, Palmer CN, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008;40:437-42. (Pubitemid 351450879)
11. Anzai N, Ichida K, Jutabha P, Kimura T, Babu E, Jin CJ, et al. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem. 2008;283:26834-8.
12. Caulfield MJ, Munroe PB, O'Neill D, Witkowska K, Charchar FJ, Doblado M, et al. SLC2A9 is a high-capacity urate transporter in humans. PLoS Med. 2008;5:e197.
13. Woodward OM, Köttgen A, Coresh J, Boerwinkle E, Guggino WB, Köttgen M. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA. 2009;106:10338-42.
14. Anzai N, Miyazaki H, Noshiro R, Khamdang S, Chairoungdua A, Shin HJ, et al. The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C terminus. J Biol Chem. 2004;279:45942-50. (Pubitemid 39491587)
15. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008;9:356-69. (Pubitemid 351556063)
16. Li S, Sanna S, Maschio A, Busonero F, Usala G, Mulas A, et al. The GLUT9 gene is associated with serum uric acid levels in Sardinia and Chianti cohorts. PLoS Genet. 2007;3:e194.
17. Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008;82:139-49. (Pubitemid 351735954)
18. Döring A, Gieger C, Mehta D, Gohlke H, Prokisch H, Coassin S, et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet. 2008;40:430-6. (Pubitemid 351454014)
19. Stark K, Reinhard W, Neureuther K, Wiedmann S, Sedlacek K, Baessler A, et al. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS One. 2008;3:e1948.
20. Brandstätter A, Kiechl S, Kollerits B, Hunt SC, Heid IM, Coassin S, et al. Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care. 2008;31:1662-7.
21. Dehghan A, Köttgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372:1953-61.
22. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. Plos Genet. 2009;5:1-10.
23. Hollis-Moffatt JE, Xu X, Dalbeth N, Merriman ME, Topless R, Waddell C, et al. Role of the urate transporter SLC2A9 gene in susceptibility to gout in New Zealand Māori, Pacific Island, and Caucasian case-control sample sets. Arthritis Rheum. 2009;60: 3485-92.
24. Tu HP, Chen CJ, Tovosia S, Ko AM, Lee CH, Ou TT, et al. Associations of a nonsynonymous variant in SLC2A9 with gouty arthritis and uric acid levels in Han Chinese and Solomon Islanders. Ann Rheum Dis. 2010;69:887-90.
25. Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology (Bethesda). 2005;20:125-33. (Pubitemid 40627553)
26. Enomoto A, Endou H. Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol. 2005;9:195-205. (Pubitemid 41414118)
27. Anzai N, Enomoto A, Endou H. Renal urate handling: clinical relevance of recent advances. Curr Rheumatol Rep. 2005;7: 227-34.
28. Mount DB, Kwon CY, Zandi-Nejad K. Renal urate transport. Rheum Dis Clin North Am. 2006;32:313-31. (Pubitemid 43728821)
29. Taniguchi A, Kamatani N. Control of renal uric acid excretion and gout. Curr Opin Rheumatol. 2008;20:192-7. (Pubitemid 351339892)
30. Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem. 2004;279:16229-36. (Pubitemid 38509316)
31. Ekaratanawong S, Anzai N, Jutabha P, Miyazaki H, Noshiro R, Takeda M. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci. 2004;94:297-304. (Pubitemid 38470739)
32. Anzai N, Jutabha P, Kimura T, Fukutomi T. Urate transport: relationship with serum urate disorder. Curr Rheumatol Rev. 2011;7:123-31.
33. Bibert S, Hess SK, Firsov D, Thorens B, Geering K, Horisberger JD, et al. Mouse GLUT9: evidences for a urate uniporter. Am J Physiol Renal Physiol. 2009;297:F612-9.
34. Dinour D, Gray NK, Campbell S, Shu X, Sawyer L, Richardson W, et al. Homozygous SLC2A9 mutations cause severe renal hypouricemia. J Am Soc Nephrol. 2010;21:64-72.
35. Preitner F, Bonny O, Laverrière A, Rotman S, Firsov D, Da Costa A, et al. Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy. Proc Natl Acad Sci USA. 2009;106:15501-6.
36. Krishnamurthy P, Schuetz JD. Role of ABCG2/BCRP in biology and medicine. Annu Rev Pharmacol Toxicol. 2006;46:381-410. (Pubitemid 43271195)
37. Ishikawa T, Nakagawa H. Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics. J Exp Ther Oncol. 2009;8:5-24.
38. Huls M, Brown CD, Windass AS, Sayer R, van den Heuvel JJ, Heemskerk S, et al. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int. 2008;73:220-5.
39. Doyle LA, Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene. 2003;22: 7340-58. (Pubitemid 37487163)
40. Reimer RJ, Edwards RH. Organic anion transport is the primary function of the SLC17/type I phosphate transporter family. Pflugers Arch. 2004;447:629-35. (Pubitemid 38241447)
41. Uchino H, Tamai I, Yamashita K, Minemoto Y, Sai Y, Yabuuchi H, et al. p-Aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1. Biochem Biophys Res Commun. 2000;270:254-9. (Pubitemid 30440424)
42. Urano W, Taniguchi A, Anzai N, Inoue E, Kanai Y, Yamanaka M, et al. Sodium-dependent phosphate cotransporter type 1 (NPT1) sequence polymorphisms in male patients with gout. Ann Rheum Dis. 2010;69:932-3.
43. Melis D, Havelaar AC, Verbeek E, Smit GP, Benedetti A, Mancini GM, et al. NPT4, a new microsomal phosphate transporter: mutation analysis in glycogen storage disease type Ic. J Inherit Metab Dis. 2004;27:725-33. (Pubitemid 39433599)
44. Jutabha P, Anzai N, Kitamura K, Taniguchi A, Kaneko S, Yan K, et al. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate. J Biol Chem. 2010;285:35123-32.
45. Shibui A, Tsunoda T, Seki N, Suzuki Y, Sugane K, Sugano S. Isolation and chromosomal mapping of a novel human gene showing homology to Na+/PO4 cotransporter. J Hum Genet. 1999;44:190-2. (Pubitemid 29219906)
46. Halestrap AP, Meredith D. The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 2004;447:619-28. (Pubitemid 38241446)
47. van der Harst P, Bakker SJ, de Boer RA, Wolffenbuttel BH, Johnson T, et al. Replication of the five novel loci for uric acid concentrations and potential mediating mechanisms. Hum Mol Genet. 2010;19:387-95.
48. Kocher O, Comella N, Tognazzi K, Brown LF. Identification and partial characterization of PDZK1: a novel protein containing PDZ interaction domains. Lab Invest. 1998;78:117-25. (Pubitemid 28074315)
49. Lamprecht G, Seidler U. The emerging role of PDZ adapter proteins for regulation of intestinal ion transport. Am J Physiol Gastrointest Liver Physiol. 2006;291:G766-77. (Pubitemid 44772003)
50. Miyazaki H, Anzai N, Ekaratanawong S, Sakata T, Shin HJ, Jutabha P, et al. Modulation of renal apical organic anion transporter 4 function by two PDZ domain-containing proteins. J Am Soc Nephrol. 2005;16:3498-506. (Pubitemid 46211270)
51. Noshiro R, Anzai N, Sakata T, Miyazaki H, Terada T, Shin HJ, et al. The PDZ domain protein PDZK1 interacts with human peptide transporter PEPT2 and enhances its transport activity. Kidney Int. 2006;70:275-82. (Pubitemid 44086577)
52. Jutabha P, Anzai N, Endou H, Kanai Y. Interaction of the multivalent PDZ domain protein PDZK1 with type I sodium-phosphate cotransporter (NPT1). J Am Soc Nephrol. 2005;16:350A.
53. Fukutomi T, Anzai N, Jutabha P, Kanai Y, Sakurai H. Interaction of the multivalent PDZ proteins with sodium-phosphate transporter 4 (NPT4). J Pharmacol Sci. 2011;115:68P.
54. Thomson RB, Wang T, Thomson BR, Tarrats L, Girardi A, Mentone S, et al. Role of PDZK1 in membrane expression of renal brush border ion exchangers. Proc Natl Acad Sci USA. 2005;102:13331-6. (Pubitemid 41325023)
55. Anzai N, Endou H. Drug discovery for hyperuricemia. Expert Opin Drug Discov. 2007;2:1251-61. (Pubitemid 47496482)
56. Srivastava S, Anzai N, Miyauchi S, Miura D, Fukutomi T, et al. Identification of the multivalent PDZ protein PDZK1 as a binding partner of sodium-coupled monocarboxylate cotransporter SMCT1 (SLC5A8) and SMCT2 (SLC5A12) by yeast two-hybrid assay. J Pharmacol Sci. 2009;109:68.
57. Wu XW, Muzny DM, Lee CC, Caskey CT. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol. 1992;34:78-84.
58. Watanabe S, Kang DH, Feng L, Nakagawa T, Kanellis J, Lan H, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension. 2002;40:355-60. (Pubitemid 35006723)
59. Wu X, Wakamiya M, Vaishnav S, Geske R, Montgomery C Jr, Jones P, et al. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci USA. 1994;91:742-6. (Pubitemid 24041478)